IGC icon

IGC Pharma
IGC

Overview Fund Activity

9 hedge funds and large institutions have $223K invested in IGC Pharma in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$115K
2
UBS Group
2
UBS Group
Switzerland
$29K
3
PAM
3
Panagora Asset Management
Massachusetts
$38K
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$4K
5
Deutsche Bank
5
Deutsche Bank
Germany
$4K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$10K
Name Market Value Shares Shares
Change 		Shares
Change %
VKH
1
Virtu KCG Holdings
New York
$115K 281,304 +251,493 +844%
PAM
2
Panagora Asset Management
Massachusetts
$38K 93,354 +44,195 +90%
UBS Group
3
UBS Group
Switzerland
$29K 71,722 +67,837 +1,746%
Creative Planning
4
Creative Planning
Kansas
$21K 65,049 – –
Citadel Advisors
5
Citadel Advisors
Florida
$10K 23,776 -67,680 -74%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$4K 10,000 +10,000 New
Deutsche Bank
7
Deutsche Bank
Germany
$4K 11,475 +11,475 New
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$1K 1,500 – –
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$1K 2,876 +2,876 New